More Business Wire
View Older Stories View Newer Stories-
Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief
-
Odyssey Investment Partners Promotes Three Investment Professionals
-
Advancing Medical Nutrition: Hologram Sciences Announces collaboration with Mayo Clinic to Develop Precision Nutrition Platform
-
Jennifer Patterson joins Haug Partners LLP’s Antitrust group
-
Red Robin Gourmet Burgers, Inc. to Participate in Two Investor Conferences in January
-
Berkshire Hathaway Specialty Insurance Enhances Multinational Capabilities
-
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference
-
OcuTerra Therapeutics Announces Last Patient Completes Final Visit in Nesvategrast (OTT166) Eye Drop Phase 2 DR:EAM Clinical Trial in Diabetic Retinopathy
-
Suffolk Adds Experienced Leader William Ellis to Mission Critical Group as Vice President, Business Development to Drive Strategic Growth
-
Energize Marketing Names Melissa Stillwell to Spearhead Customer Success and Operations Department
-
Rapport Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
WNS to Release Fiscal 2024 Third Quarter Financial and Operating Results on January 18, 2024
-
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
-
Immusoft To Present on ISP-001 Clinical Trial at WORLDSymposium™ 2024 Conference
-
Atlantic Union Bankshares Corporation To Release Fourth Quarter and Full Year 2023 Financial Results
-
Sonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® Procedure
-
Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
-
Evolv Technology to Present at 26th Annual Needham Growth Conference
-
Intuit TurboTax's 2024 "Make Your Moves Count" Campaign Highlights Its Tax Experts, AI Technology and Filing Solutions Ensuring the Best Tax Outcome for All Types of Filers
-
UnCruise Adventures Launches ‘Leap into Adventure’ WAVE Season Deals
-
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
-
ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome
-
EnerSys Announces Proposed Offering of Senior Notes
-
Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
ReCode Therapeutics Doses First Patient in Phase 1 Clinical Study of Novel mRNA-based Therapy for the Treatment of Primary Ciliary Dyskinesia
-
Cathedra Bitcoin Provides Operations Update
-
Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
-
SentinelOne® to Expand Cloud Security Capabilities with Acquisition of PingSafe
-
Perion Network Announces Conference Participation in January 2024
-
Melt Pharmaceuticals Provides Corporate Update
-
LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients
-
Alliant Insurance Services Acquires PBC Employee Benefits Division, Extending Oregon Footprint
-
SkyWater Technology Announces Participation in 26th Annual Needham Growth Conference
-
Universal Electronics Inc. to Participate in the 26th Annual Needham Growth Conference
-
Eden Park to Launch MobileShield²²² at CES: Introducing Continuous Disinfection for Personal and Crowded Spaces
-
Oligo Factory Announces GMP Compliance
-
Fortive Announces Completion of EA Elektro-Automatik Acquisition
-
Farmers Edge and LTIMindtree Unveil FEIL in Mumbai: A Pioneering Agricultural Innovation Hub Redefining Farming in India
-
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Arrowhead Pharmaceuticals Announces Pricing of $450.0 Million Underwritten Offering of Common Stock
-
Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer
-
Aeva Selected by Top Global Automotive OEM to Directly Supply LiDAR for its Series Production Program
-
Liberty Energy Launches Bettering Human Lives Foundation to Advance Clean Cooking Solutions
-
Upstream Bio Announces Dosing of First Patients in a Phase 2 Clinical Trial of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
-
Harrow Partners with Leading Healthcare Market Access Technology Platforms
-
Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader, Paul Grayson, as CEO
-
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target
-
EarthOptics Passes One Million Physically Mapped Acres, Leads Digital Soil Revolution
-
First Foundation Inc. Announces Fourth Quarter 2023 Earnings Conference Call Details
